Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Addressing New Treatment Approaches for Melanoma and Carcinoma
- Melanoma 2020

Welcome Message

Global Summit on Melanoma and Carcinoma provides a rare platform to meet inspiring speakers and experts around the world. Our mission is to have researchers, scientists, doctors, professors and students to come together and share their knowledge for the development of science and society.

Melanoma 2020, anticipates more participants around the globe with

·         Thought provoking Keynote lectures

·         Interactive Oral and Poster presentation

·         Speculative Workshop

·         Remarkable Exhibitions

·         Extravagant Sponsorship opportunities

·         Media partners and Collaborators

This is a prestigious chance to draw in with the world wide group of experts endeavouring to battle against cancer and to achieve remarkable success in the Field of "Melanoma and Carcinoma".

About Conference

Melanoma 2020 cordially invites all the delegates across the globe for the Global Summit on Melanoma and Cancer which is going to be held in the month of July 29-30, 2020 at Singapore.

We take immense pleasure by welcoming you to share your valuable thoughts and ideas in our Melanoma 2020 Conference which is aimed to bring in more insights in the era of Melanoma and Carcinoma and to make the world a better place to live in.

Why should you attend?

·         We extend you an opportunity to present your work in front of eminent people from the field.

·         Possibility of listening to the most renowned scientists and professors under one roof.

·         Accessibility to the World’s leading industries in oncological field.

·         An international recognition for your research.

Target Audience

·         Health Professional

·         Drug Manufacturing Companies

·         Radiation Therapist

·         Oncology Societies

·         Clinical Researchers

·         Leading world Doctors

·         Young researchers

·         Students and delegates

Why Singapore?

Besides having a remarkable conference, you can also explore the beautiful county Singapore as it stand as a birthplace to several dazzling tourists’ spots. The Orchard Road district, Night Safari, Singapore Zoo, River Safari, Jurong Bird Park, Sentosa Island are the places which must be visited and these destination will give an unmatched experience to all visitors.

 

Sessions / Tracks

Cancer Science and Cancer Therapies

Cancer therapy is a latest way of treating the cancer that make use of drugs or other material substances to identify and invade on cancer cells, generally while little damage is happening to normal cells. Targeted medical care is manufacturing the expansion of the many cancer treatment regimens. Molecularly targeted therapy is one among the key modalities of medical treatment for cancer. The Drugs exerted by specific targeting genes. These genes are initiated in cancer cells or in cells linked to cancer growth, such as blood vessel cells. As arrangements of molecular medicine, targeted therapy blocks the evolution of cancer cells by interloping with specific targeted molecules required for carcinogenesis and tumour growth, instead of simply interfering with all rapidly dividing cells. 

Cancer Science | Cancer Science Conference | Cancer Science and Therapy | Radiation Oncology 2020 | Radiation Oncology Conference

Related Societies

American Society of Clinical Oncology - ASCO, America, Community Oncology Alliance - COA, America, Society of Surgical Oncology - SSO, America, American Society of Therapeutic Radiology and Oncology - ASTRO, America, American Society of Blood and Marrow Transplantation - ASBMT, America, American Society of Haematology - ASH, America, American Association of Cancer Research - AACR, America, American Cancer Society- ACS, National Cancer Institute- NCI, America, National Comprehensive Cancer Network- NCCN

Related Conferences

42nd Euro-Global Summit on Cancer Therapy & Radiation Oncology, Barcelona, Spain, July 22-23, 2020, 32nd International Conference on Cancer Research and Therapy, Osaka, Japan, February 17-18-2020, 3rd Cancer Diagnostics & Treatment Conference, Frankfurt, Germany, November 11-12 2019, 5th International Conference on Preventive Oncology, Berlin, Germany, July 09-10, 2020.

Cancer Prevention

Between 30-50% of all cancer cases are unit preventable. Interference offers the foremost economical long strategy for the management of cancer. During this session, we have a tendency to area unit to debate well the chances of preventing cancer and also the stages and strategies concerned to try so!

Cancer prevention medicine | Cancer prevention tests | Cancer Science | Cancer Science Conference | Cancer Science and Therapy | Radiation Oncology 2020 | Radiation Oncology Conference

Related Societies

The Society of Gynaecologic Oncology, Canada, American Society of Breast Surgeons, America, Society for Haematology and stem cells, The Connective Tissue Oncology Society, Egypt, Musculoskeletal Tumour Society, America. American Cancer Society- ACI, America,  National Cancer InstituteNCI, America, National Comprehensive Cancer Network- NCCN, American Head and Neck Society, America, Society for Melanoma Research, America, Kidney Cancer Association, America.

Related Conferences

5th International Conference on Preventive Oncology, London, Germany, July 09-10, 2020, 42nd Euro-Global Summit on Cancer Therapy & Radiation Oncology, Barcelona, Spain, July 22-23, 2020, 32nd International Conference on Cancer Research and Therapy, Osaka, Japan, February 17-18-2020, 4th DNA Repair/Replication Structures and Cancer Conference, 16 Feb 2020 - 20 Feb 2020 Nassau, The Bahamas, 18th International Congress On Targeted Anticancer Therapies, Paris, France, March 02 – 04, 2020, DNA Damage Responses and Cancer: Innovations from Radiobiology to Radiotherapy, Cambridge, United Kingdom, 30 Mar - 01 Apr, 2020.

Cancer Chemotherapy

Chemotherapy could be a kind of cancer treatment that uses one or a lot of anti-cancer medicine as a part of a homogenous therapy program. Chemotherapy is also given with a curative intent, or it's going to aim to prolong life or to cut back symptoms. Increasing the effectiveness of treatment with reduced side effects is about to be explored in this session.

Chemotherapy for Cancer | Chemotherapy Process | Chemotherapy Drugs | Radiation Oncology 2020 | Radiation Oncology Conference | Cancer Science Conference

Related Societies

American Society of Clinical Oncology - ASCO, America, Community Oncology Alliance - COA, America, Society of Surgical Oncology - SSO, America, American Society of Therapeutic Radiology and Oncology - ASTRO, America, American Society of Blood and Marrow Transplantation - ASBMT, America, American Society of Haematology - ASH, America, American Association of Cancer Research - AACR, America, American Cancer Society- ACS, National Cancer Institute- NCI, America, National Comprehensive Cancer Network- NCCN

Immunotherapy and Immuno oncology

Immuno-oncology is a unique approach that uses the body’s natural immune system to fight against the disease. Some immunotherapies work by activating the immune system and some by suppressing the immune system, without targeting specific cancer cells.

Immunotherapy Drugs | Immunotherapy Side Effects | Immnuo-oncology Drugs | Radiation Oncology Conference | Cancer Science Conference| Radiation Oncology 2020

Related Societies

Society of Urologic Oncology, America, Society of Interventional Radiology, America, Association for Cancer Surgery, London, Paediatric Radiation Oncology Society,  American College of Radiation Oncology, America, Society for Integrative Oncology, America, American Academy of Hospice and Palliative Medicine, America,  Society for Immunotherapy of CancerAmerican Psychosocial Oncology Society, America, American Society of Preventive Oncology, America.

Related Conferences

5th International Conference on Preventive Oncology, London, Germany, July 09-10, 2020, 42nd Euro-Global Summit on Cancer Therapy & Radiation Oncology, Barcelona, Spain, July 22-23, 2020, 32nd International Conference on Cancer Research and Therapy, Osaka, Japan, February 17-18, 2020, 20th Global Cancer Summit, Kyoto, Japan, March 30-31, 2020, 5th World Congress on Frontiers in Cancer Research and Therapy, Tokyo, Japan, April, 13-14, 2020.

 

Market Analysis

MARKET ANALYSIS OF MELANOMA AND CARCINOMA

Cancer includes a widespread prevalence worldwide but Melanoma is a serious form of skin cancer which begins in the cell called melanocytes whereas it is found to be less common that Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Melanoma and Carcinoma is considered to be more dangerous than any other cancer types because of its ability to spread to other organs in a faster rate. If not treated early, this may turn to deadly disease. These kinds of risk factors and increasing incidence of melanoma and carcinoma drive the market growth.

Exposure to sun stands as the most preventable risk factor for all skin cancer. According to the survey done by the National Cancer Institute (NCI), the rate of new Melanoma and Carcinoma cases among the American adults has tripled, in detail; in the year 1975 the melanoma affected rate was 7.9 per 100,000 but in the year 2014 the rate has been increased to 25.2 per 100,000. In addition among both men and women the new melanoma cases increases at a rate of 1.7% and 1.4% per year respectively which is had been stated by Federal Centers for Disease Control and Prevention (CDC).

The below chart depicts the range of people getting affected by melanoma and carcinoma.



As per American Society of Clinical Oncology (ASCO), it is estimated that more than three million people in the US are being diagnosed with skin cancer every single year. Also it is found that Basal Cell Carcinoma is more common than Squamous Cell Carcinoma. Added to this Canadian Cancer Society (CSS) states that non melanoma skin cancer is the most common among Canadians and it roughly adds upto 40% of all new cancer cases in Canada.

It is expected that North America will dominate the market in the forecast period. As per the records of American Academy of Dermatology, skin cancer prevails as the most common cancer type in US. It is identified that 9,500 US citizens is being diagnosed with skin cancer every single day. The increased incidence of skin cancer in the region of North America stands as the major reason for increase in the market growth. Also the emerging advancements in diagnosing the skin cancer which includes Photodynamic Therapy (PDT) and Handheld Melanoma Scanner being used widely also leads to growth of market.

 

Handheld Melanoma Scanner

The advanced medical device which is widely being used for the diagnosis of Melanoma is the Handheld Scanner. The Signs of Melanoma is being detected by this Handheld Scanner and the working principle of this scanner is same as that of imaging technology used in missile navigation system. These scanners are used for scanning and detecting the moles and give more information about the moles whether it is dangerous or not. Handheld Scanners is considered to be the effective and reliable tool to detect skin cancer tumour signs.

The Handheld Scanners is expected to expand firmly during 2017-2024 which is considered to be the forecast period. The wide prevalence of melanoma and carcinoma and improvement in health care field boosts up the market value. As skin cancer being the common cancer type in North America, it is anticipated that they will dominate the global Handheld Scanner market. In addition to North America, Asian countries like India, China and Japan also contribute some part towards the global market value.

In addition to the above mentioned reasons for the growth of Handheld Melanoma Scanner, early detection of melanoma cancer signs for ensuring proper treatment is also considered to be major factor for the growth of global market. Also investment done by the skin cancer diagnostic and therapeutic companies and various government initiatives make up the growth of market of handheld melanoma scanners.

Melanoma and Carcinoma Therapeutics

The melanoma and carcinoma therapeutics market has a good market growth rate due to rapid increase in skin cancer cases, initiatives taken by the government to detect melanoma in early stage and boom of technological advancements. According to the World Health Organisation (WHO) statistics, approximately 2 million people are affected by non-melanoma cancer and 132,000 people are affected by melanoma and carcinoma. Also Skin Cancer Foundation states that out of five, one American develops skin cancer during his/her lifetime. In addition American Cancer Society had estimated that 91,270 new melanoma cases were identified in US in the year 2018 alone.

And hence preventive medicine plays a major role in the diagnosing and treatment of Melanoma whereas Immune Therapy is considered to be the best in therapeutics segments during the forecast period. To destroy the cancer cell in an effective way, immune therapy is used which stimulate a person’s immune system to identify and destroy cancer cell. Immune therapy holds the largest share in the melanoma and carcinoma therapeutics. Many advanced drugs like checkpoint inhibitors are being used in immune therapy to treat melanoma and carcinoma. This stands as the major reason for the adopting immunotherapy to treat melanoma and carcinoma.

Absence of Accurate Diagnostic Method

The other most important factor which boosts up the market is the absence of accurate diagnostic method. As the incidence of melanoma and carcinoma increases worldwide, the researchers and scientists started focusing more on precise methods of cancer diagnosis with cost effectiveness. The Agency of Healthcare Research and Quality says that, cancer has become the expensive condition to treat in United States. In the other hand, the insurance providers started shifting a huge portion of medical expenses to patients. This led to the increased cost in diagnosing and treating skin and other types of cancers. The Centres for Disease Control and Prevention (CDC) projects that, the cost of treating patients suffering from melanoma and carcinoma will increase to $1.6 billion to $457 million by 2030. Without accurate diagnostic and preventive medicines, the cost of treating melanoma and carcinoma will increase in the upcoming years.

 

To Collaborate Scientific Professionals around the World

Conference Date July 29-30, 2020
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Join The Discussion

Contact Desk

Sponsorship / Exhibitor/ Advertising

Joseph

sponsoraac@alliedacademies.com

+44 20 3769 1755 Ext:5041

General Queries Whatsapp @

+441258650017

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
oncology@tumorconferences.com
Sponsorship / Exhibitor/ Advertising
sponsoraac@alliedacademies.com
General Queries Whatsapp @
More details about sponsorship:sponsors@alliedacademies.com

Highlights from last year's Convention

Copyright © 2019-2020 Allied Academies, All Rights Reserved.